Inclisiran Suppliers & Bulk Manufacturers
Available Forms: injection (prefilled syringe)
Available Strengths: 300 mg
Reference Brands: Leqvio (USA/EU)
Category: Heart Disorder
Inclisiran is a small interfering RNA (siRNA) therapy that works by reducing the production of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in the liver, which in turn increases the number of LDL receptors and helps remove more LDL cholesterol from the blood. It is used to lower LDL cholesterol in patients with high cholesterol (hypercholesterolemia) or atherosclerotic cardiovascular disease, especially when statins alone are insufficient or not tolerated. Inclisiran is available in injection (prefilled syringe) and strengths such as 300 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Inclisiran is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Inclisiran can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Inclisiran is used to lower low‑density lipoprotein cholesterol (LDL‑C) in adults with high cholesterol, including those with heterozygous familial hypercholesterolemia, and in people with atherosclerotic cardiovascular disease who need additional LDL‑C reduction beyond diet and maximally tolerated statin therapy.
Inclisiran is a synthetic small interfering RNA (siRNA), a chemically modified double‑stranded oligonucleotide that targets mRNA for the protein PCSK9 in liver cells, preventing its production.
The trade name of Inclisiran is Leqvio.
Inclisiran (Leqvio) is manufactured and marketed by Novartis.
The generic name is Inclisiran.
The brand name is Leqvio.
Inclisiran is produced by Novartis under global regulatory approvals.
Related Products
Acebutolol Hydrochloride
Strength:
200 mg, 400 mg
Form: Capsules
Reference Brands: Sectral (USA)
View Details
Dehydrated Alcohol
Strength:
≥99% ethyl alcohol
Form: Injection
Reference Brands: ABLYSINOL (USA)
View Details
Nicardipine Hydrochloride
Strength:
20 mg, 30 mg, 40 mg, 2.5 mg/mL
Form: Capsules / Injection
Reference Brands: Cardene (USA),
View DetailsQuick Response Guaranteed | Verified Suppliers
